Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Mumbai, Maharashtra, India In 1983 was created Sun Pharma, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Mumbai. The company was established in Asia in India.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Sun Pharma, startups are often financed by Lundbeckfonden Ventures, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Lundbeckfonden Ventures, 5AM Ventures.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Krystal Biotech, scPharmaceuticals, Tarsius Pharma Ltd. The fund has exact preference in some founders of portfolio startups.
The typical startup value when the investment from Sun Pharma is 10-50 millions dollars. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2017. Considering the real fund results, this Corporate Investor is 80 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. Comparing to the other companies, this Sun Pharma performs on 38 percentage points more the average number of lead investments.
Related Funds
| Fund Name | Location |
| Avellinia Capital | England, London, United Kingdom |
| CreativeEurope MEDIA | Lithuania, Vilniaus Apskritis, Vilnius |
| Danish Microfinance Partners | - |
| Dazixian Shangshi Guanli Zixun Youxian Gongsi | Chengguan District, China, Lhasa |
| Efficient Capacity LLC | Belvedere Tiburon, California, United States |
| Fellowship | Japan, Tokyo |
| First Imagine! Ventures | England, London, United Kingdom |
| Ghost Angel | - |
| Home Inn | China, Shanghai |
| Ingressive Capital | Lagos, Lagos, Nigeria |
| Kitara Capital | Masqat, Muscat, Oman |
| MDA | Boston, Massachusetts, United States |
| New Business Venture Fund | Gullbringusysla, Iceland, Reykjavík |
| Pappas Ventures | Durham, North Carolina, United States |
| Qixin Yongyan Investment | China, Shanghai |
| Qtone Education Group | China, Guangdong Province, Panyu District |
| Rugged VC | - |
| Taihe Youdian | China, Fujian, Xiamen |
| Taiwan Biotech | Taitung County, Taiwan, Taoyüan |
| Yaxia Jituan | Anhui, China, Ningguo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AGATSA | $3M | 19 Feb 2023 | Noida, Uttar Pradesh, India | ||
Zenotech Laboratories | $691K | 21 Mar 2022 | Hyderabad, Andhra Pradesh, India | ||
Tarsier Pharma | $3M | 10 Sep 2018 | North District | ||
Krystal Biotech | $7M | 08 Aug 2017 | Pittsburgh, Pennsylvania, United States | ||
scPharmaceuticals | $45M | 04 Jan 2017 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
